Identification of Biomarkers That Can Predict Progression from Latent Tuberculosis Infection to Active Tuberculosis Disease

Study Location:

India

Topic:

Tuberculosis

Enrollment:

Open

Trial Period:

Ongoing

Purpose: The C-TRIUMPH study has identified 20 household contacts (HHC), who have progressed to active TB from its HHCs cohort (Cohort B). Immunological profiling of TB antigen induced biosignatures, profiling of transcriptional and proteomic biosignatures should provide novel insights into the nature of the immune response that differentiates progressors to TB disease from non-progressors. We aim to measure the plasma biomarker profiles and profile microRNAs at baseline in HHC who progress versus those who do not. We will also measure the unstimulated, TB-antigen and mitogen stimulated cytokine and chemokine responses and unstimulated, TB-antigen and mitogen stimulated growth factors and other immune factors at baseline in HHC who progress versus those who do not to elucidate the differential immune profile between the 2 groups. Our study should provide us new insights into the nature of the immune signatures that differentiate progressors from non-progressor in this cohort.

Aims:
The major objectives of the study are to identify biomarkers that can accurately predict progression from latent TB infection to active TB disease,
To measure the plasma biomarker profiles at baseline in HHC who progress versus those who do not.
To profile microRNAs at baseline in HHC who progress versus those who do not.
To measure the unstimulated, TB-antigen and mitogen stimulated cytokine and chemokine responses at baseline in HHC who progress versus those who do not.
To measure the unstimulated, TB-antigen and mitogen stimulated growth factors and other immune factors at baseline in HHC who progress versus those who do not.

Adult, Pediatric, Household contacts

Categories

Location
Topic

Clinical Trials

A5279, Phase III Clinical Trial of Ultra-Short-Course...

This study will enroll HIV-infected people who do not have evidence of active TB but who are at high risk of developing active...

Read More

P1060:  Phase II, parallel, randomized, clinical trials...

A single dose of nevirapine (SD NVP) given to an HIV infected pregnant woman followed by a single dose to her infant has been...

Read More

NWCS 445: Novel Biomarkers to Shorten TB Treatment

Objectives: Primary: To develop a highly predictive algorithm that identifies TB patients who will be cured by treatment...

Read More

IMPAACT 2034 - Phase I Study of the Pharmacokinetics,...

This is a Phase I, multi-site, open-label, non-comparative study of the PK, safety, tolerability, and acceptability of a...

Read More

A5288: MULTIOCTAVE, Management Using the Latest Technologies...

The study is being done to: test a strategy of using a resistance test to choose anti-HIV drugs. Resistance tests look at the...

Read More